Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradua...查看全文
一年交易一次2018-10-19 08:05
$NewLink Genetics Corporation (NLNK)$ NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018 网页链接查看全文
WitnessBio2018-08-01 09:00
$NewLink Genetics Corporation (NLNK)$ Hammered by a series of setbacks, NewLink axes staff (again) and circles its wagons around troubled IDO program.
Endpoints查看全文
$Newlink(NLNK)$ 美东时间 2014-11-06 09:00 Before Open:NEWLINK GENETIC Earning Release . Wall St EPS Est ($):-0.41. 网页链接
$Newlink(NLNK)$ 内部交易: 2014-10-22,Quality Assurance Officer,Ramsey William J. ,卖出,10000普通股, $40.00
$Newlink(NLNK)$ 内部交易: 2014-10-22,Quality Assurance Officer,Ramsey William J. ,期权,10000普通股, $6.90
$Newlink(NLNK)$ 内部交易: 2014-10-22,董事会主席 and CEO,Link Charles J. Jr. ,卖出,25000普通股, $40.26
$Newlink(NLNK)$ 内部交易: 2014-10-16,Quality Assurance Officer,Ramsey William J. ,卖出,5000普通股, $30.00
$Newlink(NLNK)$ 内部交易: 2014-10-16,Quality Assurance Officer,Ramsey William J. ,期权,5000普通股, $7.00
$Newlink(NLNK)$ 内部交易: 2014-10-06,董事会主席 and CEO,Link Charles J. Jr. ,卖出,10000普通股, $21.86
$Newlink(NLNK)$ 内部交易: 2014-10-03,董事会主席 and CEO,Link Charles J. Jr. ,卖出,10000普通股, $23.57
$Newlink(NLNK)$ 内部交易: 2014-09-05,董事会主席 and CEO,Link Charles J. Jr. ,卖出,10000普通股, $25.07
$Newlink(NLNK)$ 内部交易: 2014-09-04,董事会主席 and CEO,Link Charles J. Jr. ,卖出,10000普通股, $26.28